Boni Ding
Impact in
-
- Chemokine receptors and signaling
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 8
- Cancer-related molecular mechanisms research 1
-
- Breast Lesions and Carcinomas 6
- Co-authors
- Liyuan Qian (14 shared papers)Wei Dong Wu (4 shared papers)Xuedong Chen (3 shared papers)Juan Zhang (2 shared papers)Jianbin Tong (3 shared papers)Yuan Le (2 shared papers)Jingcheng Shi (2 shared papers)Jufang Huang (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Frontiers in Nutrition (1 paper)The Breast (1 paper)Frontiers in Pharmacology (1 paper)Diagnostic Pathology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Boni Ding
26 papers receiving 402 citations
Peers
Comparison fields: 5 of 57
- Oncology 110
- Cancer Research 44
- Molecular Biology 138
- Pathology and Forensic Medicine 34
- Food Science 37
Countries citing papers authored by Boni Ding
This map shows the geographic impact of Boni Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boni Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boni Ding more than expected).
Fields of papers citing papers by Boni Ding
This network shows the impact of papers produced by Boni Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boni Ding. The network helps show where Boni Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Boni Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 94 | |
| 2 | 2019 | 52 | |
| 3 | Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer. | 2015 | 45 |
| 4 | 2020 | 42 | |
| 5 | 2020 | 41 | |
| 6 | 2013 | 26 | |
| 7 | 2024 | 19 | |
| 8 | 2021 | 17 | |
| 9 | 2017 | 9 | |
| 10 | 2021 | 9 | |
| 11 | 2016 | 8 | |
| 12 | 2021 | 8 | |
| 13 | 2020 | 7 | |
| 14 | 2024 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2015 | 3 | |
| 18 | 2014 | 2 | |
| 19 | 2015 | 2 | |
| 20 | 2019 | 2 |
About Boni Ding
Boni Ding is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Psychiatry and Mental health, having authored 27 papers that have together received 406 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (6 papers), Chemokine receptors and signaling (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Probiotics and Fermented Foods (2 papers), RNA modifications and cancer (1 paper) and Cancer-related molecular mechanisms research (1 paper). The work is most often cited by research in Oncology (110 citations), Cancer Research (44 citations), Molecular Biology (138 citations), Pathology and Forensic Medicine (34 citations) and Food Science (37 citations). Boni Ding has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Liyuan Qian, Wei Dong Wu, Xuedong Chen, Juan Zhang, Jianbin Tong, Yuan Le, Jingcheng Shi, Jufang Huang, Kai Liu and Ling Wang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Nutrition, The Breast, Frontiers in Pharmacology and Diagnostic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.